ROYCE & ASSOCIATES LP 13D and 13G filings for Apyx Medical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-21 12:55 pm Purchase | 2026-06-30 | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 3,274,064 7.810% | 831,029 (+34.02%) | Filing |
| 2026-01-20 10:02 am Sale | 2025-12-31 | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 2,443,035 5.950% | -139,455 (-5.40%) | Filing |
| 2024-10-15 09:18 am Purchase | 2024-09-30 | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 2,582,490 7.450% | 423,590 (+19.62%) | Filing |
| 2024-01-23 09:52 am Unchanged | 2023-12-31 | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 2,158,900 6.230% | 0 (Unchanged) | Filing |
| 2024-01-23 09:49 am Purchase | 2023-12-31 | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 2,158,900 6.230% | 2,158,900 (New Position) | Filing |